4.7 Article

Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn2B/- mouse model of spinal muscular atrophy

Journal

EXPERIMENTAL NEUROLOGY
Volume 337, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2020.113587

Keywords

Spinal muscular atrophy (SMA); P53; p21 (cdkn1a); Motor neuron; Mouse; Smn(2B/-); Survival motor neuron (SMN)

Categories

Funding

  1. NIH NINDS [R01NS060926]
  2. Muscular Dystrophy Association [MDA418685]
  3. CureSMA [DID1617, 1718, R21NS103107]
  4. Mazza Foundation
  5. National Institutes of Health Training Grant [T32NS041234]
  6. Stanley Manne Children's Research Institute
  7. Ann & Robert H. Lurie Children's Hospital of Chicago

Ask authors/readers for more resources

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by genetic deficiency of the SMN protein. Studies have shown activation of the p53 and p21 pathways in SMA mice, but they are not primary drivers of motor neuron death in milder SMA mouse models like Smn(2B/-).
Spinal muscular atrophy (SMA) is a pediatric neuromuscular disease caused by genetic deficiency of the survival motor neuron (SMN) protein. Pathological hallmarks of SMA are spinal motor neuron loss and skeletal muscle atrophy. The molecular mechanisms that elicit and drive preferential motor neuron degeneration and death in SMA remain unclear. Transcriptomic studies consistently report p53 pathway activation in motor neurons and spinal cord tissue of SMA mice. Recent work has identified p53 as an inducer of spinal motor neuron loss in severe Delta 7 SMA mice. Additionally, the cyclin-dependent kinase inhibitor P21 (Cdkn1 alpha), an inducer of cell cycle arrest and mediator of skeletal muscle atrophy, is consistently increased in motor neurons, spinal cords, and other tissues of various SMA models. p21 is a p53 transcriptional target but can be independently induced by cellular stressors. To ascertain whether p53 and p21 signaling pathways mediate spinal motor neuron death in milder SMA mice, and how they affect the overall SMA phenotype, we introduced Trp53 and P21 null alleles onto the Smn(2B/- )background. We found that p53 and p21 depletion did not modulate the timing or degree of Smn(2B/- )motor neuron loss as evaluated using electrophysiological and immunohistochemical methods. Moreover, we determined that Trp53 and P21 knockout differentially affected Smn(2B/-) mouse lifespan: p53 ablation impaired survival while p21 ablation extended survival through Smn-independent mechanisms. These results demonstrate that p53 and p21 are not primary drivers of spinal motor neuron death in Smn(2B/-) mice, a milder SMA mouse model, as motor neuron loss is not alleviated by their ablation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available